4//SEC Filing
Krebs Stephanie 4
Accession 0001209191-23-054170
CIK 0001829802other
Filed
Nov 1, 8:00 PM ET
Accepted
Nov 2, 4:53 PM ET
Size
5.7 KB
Accession
0001209191-23-054170
Insider Transaction Report
Form 4
Krebs Stephanie
Chief Business Officer
Transactions
- Award
Stock Option (Right to Buy)
2023-11-01+125,000→ 125,000 totalExercise: $0.82Exp: 2033-10-31→ Common Stock (125,000 underlying)
Footnotes (1)
- [F1]The shares subject to the option vest and become exercisable as to 25% of the shares underlying the option on November 1, 2024, and the remaining 75% of the shares underlying the Option shall vest and become exercisable in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date.
Documents
Issuer
Sensei Biotherapeutics, Inc.
CIK 0001829802
Entity typeother
Related Parties
1- filerCIK 0001998150
Filing Metadata
- Form type
- 4
- Filed
- Nov 1, 8:00 PM ET
- Accepted
- Nov 2, 4:53 PM ET
- Size
- 5.7 KB